Works matching Bacillus Calmette Guérin (BCG)

Results: 1566
    1

    Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer ( NMIBC) with emphasis on the use of bacillus Calmette- Guérin ( BCG): results of an international individual patient data survey ( IPDS)

    Published in:
    BJU International, 2013, v. 112, n. 6, p. 742, doi. 10.1111/bju.12012
    By:
    • Witjes, J. Alfred;
    • Palou, Joan;
    • Soloway, Mark;
    • Lamm, Donald;
    • Kamat, Ashish M.;
    • Brausi, Maurizio;
    • Persad, Raj;
    • Buckley, Roger;
    • Colombel, Marc;
    • Böhle, Andreas
    Publication type:
    Article
    2
    3
    4

    Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.

    Published in:
    Infectious Diseases & Therapy, 2022, v. 11, n. 6, p. 2205, doi. 10.1007/s40121-022-00703-y
    By:
    • Sinha, Sanjeev;
    • Ajayababu, Anuj;
    • Thukral, Himanshu;
    • Gupta, Sushil;
    • Guha, Subhasish Kamal;
    • Basu, Ayan;
    • Gupta, Gaurav;
    • Thakur, Prashant;
    • Lingaiah, Raghavendra;
    • Das, Bimal Kumar;
    • Singh, Urvashi B.;
    • Singh, Ravinder;
    • Narang, Rajiv;
    • Bhowmik, Dipankar;
    • Wig, Naveet;
    • Modak, Dolan Champa;
    • Bandyopadhyay, Bhaswati;
    • Chakrabarty, Banya;
    • Kapoor, Aditya;
    • Tewari, Satyendra
    Publication type:
    Article
    5
    6

    Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis.

    Published in:
    Cancers, 2023, v. 15, n. 7, p. 1937, doi. 10.3390/cancers15071937
    By:
    • Del Giudice, Francesco;
    • Asero, Vincenzo;
    • Bologna, Eugenio;
    • Scornajenghi, Carlo Maria;
    • Carino, Dalila;
    • Dolci, Virginia;
    • Viscuso, Pietro;
    • Salciccia, Stefano;
    • Sciarra, Alessandro;
    • D'Andrea, David;
    • Pradere, Benjamin;
    • Moschini, Marco;
    • Mari, Andrea;
    • Albisinni, Simone;
    • Krajewski, Wojciech;
    • Szydełko, Tomasz;
    • Małkiewicz, Bartosz;
    • Nowak, Łukasz;
    • Laukhtina, Ekaterina;
    • Gallioli, Andrea
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.

    Published in:
    2023
    By:
    • Sinha, Sanjeev;
    • Ajayababu, Anuj;
    • Thukral, Himanshu;
    • Gupta, Sushil;
    • Guha, Subhasish Kamal;
    • Basu, Ayan;
    • Gupta, Gaurav;
    • Thakur, Prashant;
    • Lingaiah, Raghavendra;
    • Das, Bimal Kumar;
    • Singh, Urvashi B.;
    • Singh, Ravinder;
    • Narang, Rajiv;
    • Bhowmik, Dipankar;
    • Wig, Naveet;
    • Modak, Dolan Champa;
    • Bandyopadhyay, Bhaswati;
    • Chakrabarty, Banya;
    • Kapoor, Aditya;
    • Tewari, Satyendra
    Publication type:
    Correction Notice
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guérin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis.

    Published in:
    2009
    By:
    • Olleros ML;
    • Vesin D;
    • Lambou AF;
    • Janssens JP;
    • Ryffel B;
    • Rose S;
    • Frémond C;
    • Quesniaux VF;
    • Szymkowski DE;
    • Garcia I;
    • Olleros, Maria L;
    • Vesin, Dominique;
    • Lambou, Agathe F;
    • Janssens, Jean-Paul;
    • Ryffel, Bernhard;
    • Rose, Stéphanie;
    • Frémond, Cécile;
    • Quesniaux, Valérie F;
    • Szymkowski, David E;
    • Garcia, Irene
    Publication type:
    journal article
    42

    Dominant-Negative Tumor Necrosis Factor Protects from Mycobacterium bovis Bacillus Calmette-Guérin (BCG) and Endotoxin-Induced Liver Injury without Compromising Host Immunity to BCG and Mycobacterium tuberculosis.

    Published in:
    Journal of Infectious Diseases, 2009, v. 199, n. 7, p. 1053, doi. 10.1086/597204
    By:
    • Olleros, Maria L.;
    • Vesin, Dominique;
    • Lambou, Agathe F.;
    • Janssens, Jean-Paul;
    • Ryffel, Bernhard;
    • Rose, Stéphanie;
    • Frémond, Cécile;
    • Quesniaux, Valérie F.;
    • Szymkowski, David E.;
    • Garcia, Irene
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Bioreactor-Grown Bacillus of Calmette and Guérin (BCG) Vaccine Protects Badgers against Virulent Mycobacterium bovis When Administered Orally: Identifying Limitations in Baited Vaccine Delivery.

    Published in:
    Pharmaceutics, 2020, v. 12, n. 8, p. 782, doi. 10.3390/pharmaceutics12080782
    By:
    • Lesellier, Sandrine;
    • Birch, Colin P. D.;
    • Davé, Dipesh;
    • Dalley, Deanna;
    • Gowtage, Sonya;
    • Palmer, Simonette;
    • McKenna, Claire;
    • Williams, Gareth A.;
    • Ashford, Roland;
    • Weyer, Ute;
    • Beatham, Sarah;
    • Coats, Julia;
    • Nunez, Alex;
    • Sanchez-Cordon, Pedro;
    • Spiropoulos, John;
    • Powell, Stephen;
    • Sawyer, Jason;
    • Pascoe, Jordan;
    • Hendon-Dunn, Charlotte;
    • Bacon, Joanna
    Publication type:
    Article
    50